Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

NCT03933696

CompletedNA

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions: Mild Cognitive Impairment, Alzheimer Disease, Type2 Diabetes

Interventions: Tailored Lighting Intervention

Countries: United States

To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).

Eligibility overview

Sex: ALL

Age: 55 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Mild cognitive impairment
* Mild Alzheimer's Disease
* Sleep Disturbance
* Live at home

Exclusion Criteria:

* Blindness
* insulin-dependent diabetes patients
* macular degeneration
* severe sleep apnea
Locations (2)
  • New Brunswick, New Jersey, United States
  • New York, New York, United States